8.00 - 8.15 - Welcome and overview of the meeting Juan Fernández-Cean |
8.15 - 10.15 - PLENARY SESSION PREVALENCE OF RISK FACTORS AND PREVALENCE OF CHRONIC KIDNEY DISEASE (CKD)
Chairperson: Garabed Eknoyan
Co-chair: Emma Schwedt
Garabed Eknoyan |
Risk Factors and Prevalence of CKD |
Kunitoshi Iseki |
Life Style related Factors and Prevalence of CKD |
Carmine Zoccali |
Light and Shades of new risk factors. |
Angel LM de Francisco |
CKD in Spain: Results of seven epidemiological studies |
|
10.15 - 10.45 - Coffee break |
10.45 - 12.45 - PLENARY SESSION SCREENING PROGRAMS
Chairperson: Angel LM de Francisco
Co-chair: Pablo Rios
Angel LM de Francisco |
Screening Techniques for detecting CKD, Public Health Perspective |
M. Krishna Mani |
Low Cost Screening and Cost Benefits Analysis |
Rachel Bregman |
Prevention of the progression of CKD is a reality. Experience in Brazil |
|
12.45 - 14.00 - Lunch |
14.00 - 16.00 - PLENARY SESSION PROGRESSION / REGRESSION OF CKD
Chairperson: Oscar Noboa
Co-chair: Marcela Daglio
León Ferder |
New insights in renin angiotensin system blockage |
Norberto Perico |
Proteinuria as a risk factor for the progression of Renal Disease |
Oscar Noboa |
Non traditional factors of progression of CKD |
Norberto Perico |
Present and future of renoprotection |
|
16.00 - 17.30 - Poster Session – Coffee break Chairpersons: Emma Schwedt - Carmine Zoccali |
17.30 - 19.30 - PLENARY SESSION HOW TO DIMINISH CV RISK IN PATIENTS WITH CKD
Chairperson: Tilman Drueke
Co-chair: José Ventura
Tilman Drueke |
Mineral and bone disorders in CKD (CKD-MBD) andcardiovascular risk |
Katherine Tuttle |
CV disease in diabetic patients with CKD: risk factors; evaluation and management of coronary heart disease |
José L. Górriz |
Anemia and CV risk in CKD |
|
